CV07050101 (CVNCOV) S / M S / M LOT: AL24504 EXP: 08/2021 // 10X7 KITS PER BOXUSE: VACCINES FOR PHASE 2B / 3 CLINICAL STUDY ACCORDING TO PROTOCOL CV-NCOV-0041 VIAL PER KIT WITH 0.55ML CONTENT (1MG R9515 / ML) INTRAMUSCULAR INJECTIONRD 2860-2021-DIGEMID / DPF / AESC / MINSA RD588-2020-OGITT / INS
CV07050101 (CVNCOV) S / M S / M LOT: AL24504 EXP: 08/2021 // 10X7 KITS PER BOXUSE: VACCINES FOR PHASE 2B / 3 CLINICAL STUDY ACCORDING TO PROTOCOL CV-NCOV-0041 VIAL PER KIT WITH 0.55ML CONTENT (1MG R9515 / ML) INTRAMUSCULAR INJECTIONRD 2860-2021-DIGEMID / DPF / AESC / MINSA RD588-2020-OGITT / INS
09-December-2021
300215900000
THE OTHER FRACTIONS OF THE BLOOD; AND MODIFIED IMMUNE PRODUCTS EVEN OBTAINED BY BIOTECHNOLOGICAL PROCESSES; VACCINES TOXINS SEE DETAILS IN SUBITEM:||AESKU DIAGNOSTICS GMBH & CO. KG
THE OTHER FRACTIONS OF THE BLOOD; AND MODIFIED IMMUNE PRODUCTS EVEN OBTAINED BY BIOTECHNOLOGICAL PROCESSES; VACCINES TOXINS SEE DETAILS IN SUBITEM:||AESKU DIAGNOSTICS GMBH & CO. KG
15-October-2023
300242000000
VACCINES FOR VETERINARY MEDICINE
VACCINES FOR VETERINARY MEDICINE
13-February-2023
300215000000
BLOOD OF PEOPLE; ANIMAL BLOOD PREPARED FOR THERAPEUTIC PROPHYLACTIC OR DIAGNOSTIC USE; IMMUNE SERUM OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS MODIFIED OR UNMODIFIED INCLUDING THOSE OBTAINED BY USING BIOTECHNOLOGICAL PROCESSES; VACCINES TOXINS CULTURES OF MICROORGANISMS (EXCLUDING YEAST) AND SIMILAR PRODUCTS: - IMMUNE SERUM OTHER BLOOD FRACTIONS AND IMMUNOLOGY PRODUCTS WHETHER OR NOT MODIFIED INCLUDING OTHER USED NO BIOTECHNOLOGICAL PROCESSES: - - IMMUNOLOGICAL PRODUCTS PACKAGED IN DOSED FORM OR PACKAGED FOR RETAIL TRADE
BLOOD OF PEOPLE; ANIMAL BLOOD PREPARED FOR THERAPEUTIC PROPHYLACTIC OR DIAGNOSTIC USE; IMMUNE SERUM OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS MODIFIED OR UNMODIFIED INCLUDING THOSE OBTAINED BY USING BIOTECHNOLOGICAL PROCESSES; VACCINES TOXINS CULTURES OF MICROORGANISMS (EXCLUDING YEAST) AND SIMILAR PRODUCTS: - IMMUNE SERUM OTHER BLOOD FRACTIONS AND IMMUNOLOGY PRODUCTS WHETHER OR NOT MODIFIED INCLUDING OTHER USED NO BIOTECHNOLOGICAL PROCESSES: - - IMMUNOLOGICAL PRODUCTS PACKAGED IN DOSED FORM OR PACKAGED FOR RETAIL TRADE